Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease
Open Access
- 27 October 2008
- journal article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 3 (1) , 17
Abstract
Background: Transcriptional dysregulation is an early, key pathogenic mechanism in Huntington's disease (HD). Therefore, gene expression analyses have biomarker potential for measuring therapeutic efficacy in pre-clinical trials, particularly those aimed at correcting gene expression abnormalities. Housekeeping genes are commonly used as endogenous references in gene expression studies. However, a systematic study comparing the suitability of candidate reference genes for use in HD mouse models has not been performed. To remedy this situation, 12 housekeeping genes were examined to identify suitable reference genes for use in expression assays. Results: We found that commonly used reference genes are dysregulated at later time points in the R6/2 mouse model of HD. Therefore, in order to reliably measure gene expression changes for use as pre-clinical trial biomarkers, we set out to identify suitable reference genes for use in R6/2 mice. The expression of potential reference genes was examined in striatum, cortex and cerebellum from 15 week old R6/2 and matched wild-type littermates. Expression levels of candidate reference genes varied according to genotype and brain region. GeNorm software was used to identify the three most stably expressed genes for each brain region. Relative quantification methods using the geometric mean of three reference genes for normalisation enables accurate determination of gene expression levels in wild-type and R6/2 mouse brain regions. Conclusion: Our study has identified a reproducible, reliable method by which we able to accurately determine the relative expression level of target genes in specific brain regions, thus increasing the potential of gene expression analysis as a biomarker in HD pre-clinical trials.Keywords
This publication has 52 references indexed in Scilit:
- Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouseHuman Molecular Genetics, 2008
- Brain‐derived neurotrophic factor over‐expression in the forebrain ameliorates Huntington’s disease phenotypes in miceJournal of Neurochemistry, 2007
- Transcriptional signatures in Huntington's diseaseProgress in Neurobiology, 2007
- Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral bloodProceedings of the National Academy of Sciences, 2007
- Quantitative expression profiling of identified neurons reveals cell-specific constraints on highly variable levels of gene expressionProceedings of the National Academy of Sciences, 2007
- Gene expression profiles in rat brain disclose CNS signature genes and regional patterns of functional specialisationBMC Genomics, 2007
- Quantification of mRNA using real-time RT-PCRNature Protocols, 2006
- Glutamine-Expanded Ataxin-7 Alters TFTC/STAGA Recruitment and Chromatin Structure Leading to Photoreceptor DysfunctionPLOS Biology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000